Companion diagnostics (CDx) are tools in the precision medicine landscape that are used in identifying patients most likely to benefit from specific therapies enabling targeted treatment. Our clients sought to target competitive intelligence exercise to understand adoption challenges, access pathways, evidence requirements and competitive positioning of these tools. We conducted data extraction from commercial and global databases for Asian countries. We generated our findings in a structure report to support internal evidence planning and access strategy development across multiple geographies. 

Therapy area: Companion Diagnostics 

Biologics are large and complex molecules derived from living cells and are increasingly becoming a component of modern medicine with expanding pipelines and posing global competition. To support strategic planning, our client sought to gain competitive intelligence insights on biologic manufacturers across Asian countries. We conducted the data extraction using commercial websites and global databases not limited to FDA, EMA and WIPO, focusing on patents, clinical developments, regulatory approvals and manufacturing licenses to generate evidence on global market understanding and pipeline assessment. 

Therapy area: Biologics